These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Primary Cutaneous Cryptococcus in a Patient With Multiple Sclerosis Treated With Fingolimod. Forrestel AK; Modi BG; Longworth S; Wilck MB; Micheletti RG JAMA Neurol; 2016 Mar; 73(3):355-6. PubMed ID: 26751160 [No Abstract] [Full Text] [Related]
6. Cutaneous cryptococcosis in a patient taking fingolimod for multiple sclerosis: Here come the opportunistic infections? Carpenter AF; Goodwin SJ; Bornstein PF; Larson AJ; Markus CK Mult Scler; 2017 Feb; 23(2):297-299. PubMed ID: 28165320 [TBL] [Abstract][Full Text] [Related]
7. Cryptococcal meningoencephalitis in immunocompetent patients: changing trends in Canada. Bestard J; Siddiqi ZA Neurology; 2010 Apr; 74(15):1233-5. PubMed ID: 20385896 [No Abstract] [Full Text] [Related]
8. Delayed diagnosis of cryptococcal meningoencephalitis due to negative cryptococcal antigen test. Kessler B; Bally F; Hewer E; Sendi P BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23365165 [TBL] [Abstract][Full Text] [Related]
9. Cryptococcal meningoencephalitis and 5-fluorocytosine. Beine JP; Lontie M; Vandepitte J Br Med J; 1971 Apr; 2(5753):107. PubMed ID: 4927910 [No Abstract] [Full Text] [Related]